Third allergic reaction to COVID-19 vaccine reported in Alaska
Severe allergic reactions can occur with any vaccine, but are extremely rare.
Watch CBS News
Severe allergic reactions can occur with any vaccine, but are extremely rare.
Army General Gustave Perna, the chief operating officer of Operation Warp Speed, gave an update Saturday on COVID-19 vaccine distribution and acknowledged there was a "miscommunication" with states about how many doses of Pfizer's COVID-19 vaccine would initially be available to them. Watch his briefing.
"Please accept my personal apologies if this was disruptive to your decision-making," said Army General Gustave Perna, the chief operating officer of Operation Warp Speed.
The authorization allows the vaccine to be distributed to people 18 or older.
"Every month is actually worse than the very worst of the AIDS epidemic that we experienced for this younger population," Dr. Jeremy Samuel Faust said of the new research.
The top congressional leaders also encouraged other lawmakers to receive the vaccine as soon as possible.
President-elect Joe Biden and Dr. Jill Biden will receive their first dose of the vaccine on Monday.
The president-elect has said he will take his vaccine in front of the media to build public confidence.
Washington Governor Jay Inslee tweeted that the news was "disruptive and frustrating."
The FDA is expected to quickly approve the vaccine for emergency use.
A Food and Drug Administration advisory panel voted to recommend Moderna's COVID-19 vaccine for emergency use authorization on Thursday. Meanwhile the rollout of Pfizer's vaccine to frontline health care workers continues. Columbia University professor of epidemiology and medicine Dr. Wafaa El-Sadr joins CBSN's "Red & Blue" anchor Elaine Quijano with more on what the safety data shows.
NFL Commissioner Roger Goodell says he wants to "honor and thank health care workers for their extraordinary service during pandemic."
The health care worker who reacted more seriously had no previous history of allergic reactions, but recovered quickly and urges others to get the shot.
"Lord of the Rings" star Ian McKellen said he felt "euphoric" after receiving the COVID-19 vaccine on Thursday.
Pfizer and Moderna could be looking at a big check once their first round of COVID vaccines are distributed, despite a non-lucrative market and pressure to keep costs low. But the key for both companies may lie in the patenting process. Quartz reporter Annalisa Merelli joined CBSN AM to explain how the COVID vaccine compares to other vaccines on the market and why the mRNA patent could have larger implications outside of coronavirus. She also gave insight to life inside Bergamo, Italy, one of the hardest-hit town earlier on in the pandemic.
"I would have no hesitation in recommending it to anyone," McKellen said.
More than a third of the 306,000 coronavirus deaths have come from long-term care facilities.
The vice president will be the most high-profile person to receive the shot publicly.
A second coronavirus vaccine could be made available in the U.S. as early as this week. The FDA is expected to authorize Moderna's vaccine for emergency use as cases skyrocket this holiday season. Dr. Leo Nissola is a medical expert and immunotherapy scientist. He joined CBSN to discuss the latest.
Moderna's coronavirus vaccine could soon be part of America's largest mass vaccination effort. The Food and Drug Administration said the vaccine is highly effective and there are "no specific safety concerns," and a panel is expected to consider the pharmaceutical company's application for emergency use this week. This comes as distribution ramps up for Pfizer's vaccine and health care systems are stretched thin as coronavirus infections skyrocket. CBS News correspondent Mola Lenghi reports on the latest developments from New York City, CBS News chief congressional correspondent Nancy Cordes reports from Washington on the need for funding to fight COVID-19, and Dr. Richard Besser, president and CEO of the Robert Wood Johnson Foundation and the former acting director of the Centers for Disease Control and Prevention, joined CBSN to discuss.
Some 145 sites around the nation, from Rhode Island to Alaska, began vaccinating health care workers.
FDA analysis of data on the vaccine confirms it's more than 94% effective. It may get the agency's stamp of approval by week's end, joining Pfizer's.
Frontline workers across the U.S. lined up to get their first doses of the coronavirus vaccine. Mola Lenghi has the latest.
Cuomo said "hope is on the way" as the first doses of the vaccine are delivered to frontline health care workers.
Science writer and New York Times columnist Carl Zimmer joined "Red and Blue" to break down how the Pfizer vaccine works and what hurdles might come up in the vaccine rollout.